Literature DB >> 11348812

The ability of pulse oximetry to screen for hypoxemia and hypercapnia in patients breathing room air.

M D Witting1, C H Lueck.   

Abstract

This study was designed to determine whether high room-air pulse oximetry can rule out hypoxemia or moderate hypercapnia. Based on retrospective analysis of 513 arterial blood gas results, oxygen saturation cutpoints were derived. Coincidentally, a room-air oxygen saturation (RAO2 sat) value of 96% was selected as a cutpoint to screen for both hypoxemia (PaO2 < 70 mm Hg) and moderate hypercapnia (PaCO2 > 50 mm Hg). These tests were validated prospectively by using a convenience sample of 213 Emergency Department patients in whom room-air arterial blood gas sampling was ordered. To detect hypoxemia, the sensitivity of RAO(2) sat < or = 96% was 1.0 [0.95-1.0, 95% confidence interval (CI)] and specificity was 0.54 (0.45-0.64, 95% CI). To detect hypercapnia, the sensitivity of RAO(2) sat < or = 96% was 1.0 (0.7-1.0) and specificity was 0.31 (0.25-0.38, 95% CI). We concluded that RAO(2) sat > or = 97% rules out hypoxemia and may also rule out moderate hypercapnia.

Entities:  

Mesh:

Year:  2001        PMID: 11348812     DOI: 10.1016/s0736-4679(01)00309-2

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  2 in total

1.  Flexibility Support for Homecare Applications Based on Models and Multi-Agent Technology.

Authors:  Aintzane Armentia; Unai Gangoiti; Rafael Priego; Elisabet Estévez; Marga Marcos
Journal:  Sensors (Basel)       Date:  2015-12-17       Impact factor: 3.576

2.  The accuracy of postoperative, non-invasive Air-Test to diagnose atelectasis in healthy patients after surgery: a prospective, diagnostic pilot study.

Authors:  Carlos Ferrando; Carolina Romero; Gerardo Tusman; Fernando Suarez-Sipmann; Jaume Canet; Rosa Dosdá; Paola Valls; Abigail Villena; Ferran Serralta; Ana Jurado; Juan Carrizo; Jose Navarro; Cristina Parrilla; Jose E Romero; Natividad Pozo; Marina Soro; Jesús Villar; Francisco Javier Belda
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.